A study reported that the interactions between interleukin-13 and interleukin-13 receptor alpha 1 (IL13RA1) contributed to cancer cell growth and metastasis, and IL13RA1 expression was associated with poor prognosis in invasive BC patients (73). This evidence concerns the gene IL13 and cancer.